Dr. Sameer G. Gupta, M.D.
Mohs Surgery (MOHS-Micrographic Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Harvard Medical School (2016)
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 239
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Medical school: Harvard Medical School
- 2016Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
MOHS-Micrographic Surgery Physician primary
MA license 282383 -
Dermatology Physician
MA license 282383
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Massachusetts General Hospital Boston, MA
- Massachusetts Eye and Ear Infirmary - Boston, MA
- Cape Cod Hospital Hyannis, MA
- Martha's Vineyard Hospital Inc Oak Bluffs, MA
Medical groups
- Massachusetts Eye and Ear Associates, Inc (433 clinicians)
- Louis Kuchnir MD PC (17 clinicians)
- Essential Dermatology Nwh PLLC (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 239
- Services billed
- 857
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 129 | 111 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 80 | 57 |
| Biopsy of related skin growth, first growth | 31 | 26 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 28 | 27 |
| New patient office or other outpatient visit, 60-74 minutes | 24 | 24 |
| Biopsy of related skin growth, each additional growth | 21 | 12 |
| Established patient office or other outpatient visit, 30-39 minutes | 18 | 17 |
| New patient office or other outpatient visit, 30-44 minutes | 17 | 17 |
| Established patient office or other outpatient visit, 40-54 minutes | 17 | 13 |
| Established patient office or other outpatient visit, 10-19 minutes | 16 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Doxycycline Monohydrate Other prescribers in Boston, MA | 112 |
| Erivedge (vismodegib) | 24 |
| Fluorouracil Other prescribers in Boston, MA | 15 |
| Cephalexin Other prescribers in Boston, MA | 14 |
| Odomzo (sonidegib phosphate) | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 11 payments worth $11,201 in total to this clinician.
| Sun Pharmaceutical Industries Inc. | $9,201 |
|---|---|
| Ars Pharmaceuticals Operations, Inc. | $2,000 |
| Consulting Fee | $7,500 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $2,000 |
| Travel and Lodging | $1,320 |
| Food and Beverage | $381 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. Sep 27, 2025 | Consulting Fee Odomzo · Oncology | $7,500 |
| Ars Pharmaceuticals Operations, Inc. Oct 27, 2025 | Compensation for services other than consulting (speaking, faculty) NEFFY · ALLERGY | $2,000 |
| Sun Pharmaceutical Industries Inc. Sep 27, 2025 | Travel and Lodging Odomzo · Oncology · travel to Philadelphia, PA · in-kind | $516 |
| Sun Pharmaceutical Industries Inc. Sep 27, 2025 | Travel and Lodging Odomzo · Oncology · travel to Philadelphia, PA · in-kind | $380 |
| Sun Pharmaceutical Industries Inc. Sep 27, 2025 | Travel and Lodging Odomzo · Oncology · travel to Philadelphia, PA · in-kind | $348 |
| Sun Pharmaceutical Industries Inc. Sep 27, 2025 | Travel and Lodging Odomzo · Oncology · travel to Philadelphia, PA · in-kind | $47.79 |
| Sun Pharmaceutical Industries Inc. Sep 26, 2025 | Travel and Lodging Odomzo · Oncology · travel to Philadelphia, PA · in-kind | $27.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.